Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation (POPLAR). The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Background. The Project.

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

JULY 13, 2022

Regulatory bodies in Canada and across the world are watching Canada’s fledgling psychedelics industry and how it performs in quality, safety, and efficacy,” said Parker. “So, VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

Cannabis Law Report

MAY 26, 2022

NEO: AWKN ) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction, announced today the filing of a Patent Cooperation Treaty (PCT) application for the treatment of behavioral addictions with ketamine and ketamine-assisted psychotherapy.

Treatment 52

Treatment Research and Development Therapy Data 52

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

MMJ Recs

JANUARY 20, 2024

With a nuanced approach to medical marijuana laws, the state has embarked on a journey that seeks to balance patient well-being, regulatory oversight, and societal concerns. Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment!

Law 52

Law Marijuana Patients Chronic Pain 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. Vilmarie Fraguada Narloch, PsyD, is a licensed clinical psychologist in Chicago, Illinois, focusing on integrated treatment of co-occurring mental health and substance use disorders and psychedelic-assisted therapy. Wednesday, December 8th from 12:00-2:00pm PST.

Safety 52

Safety Medicine Therapy Research and Development 52

Cannabis Law Report

MARCH 31, 2021

Meet the women who risked their credibility and safety to research psychedelic treatment and therapy long before they shared any… Read More.

Therapy 98

Therapy Safety Treatment 98

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. “We Food and Drug Administration (FDA) for use in the U.S. In the U.S.,

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

FEBRUARY 28, 2022

Moreover, because Indigenous communities pioneered many aspects of modern psychedelic therapies, their patenting by Western corporations may promote biopiracy, the exploitation of Indigenous knowledge without compensation. MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study , 27 NATURE MED.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

MMJ Recs

MAY 19, 2024

However, by researching for the right knowledge and guidance, incorporating medical marijuana into your wellness or treatment routine can be a smooth and beneficial experience. These professionals possess the expertise and knowledge necessary to guide patients through the process of incorporating medical marijuana into their treatment plans.

Marijuana 52

Marijuana Consumption Treatment Strains 52

Cannabis Law Report

NOVEMBER 4, 2021

The Oregon Psilocybin Advisory Board (Advisory Board) held a meeting on October 27 to begin fine tuning recommendations for the first regulated psilocybin treatment model in the United States. Measure 109 requires the Advisory Board to give recommendations to OHA on the efficacy and safety of psilocybin therapy.

Law 52

Law Therapy Treatment Policy 52

MMJ Recs

APRIL 1, 2024

We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience.

Dispensary 52

Dispensary Programs Access Patients 52

United Patients Group

JULY 7, 2023

3) Helps Manage Nausea and Vomiting Medical cannabis can be used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and other medical treatments. Nausea and vomiting are common side effects of these treatments and can significantly impact a person’s quality of life.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

MMJ Recs

MARCH 6, 2024

From its historical origins to the present day, you’ll explore how attitudes, laws, and scientific advancements have shaped its acceptance. However, disparities between state and federal laws pose challenges, creating a complex regulatory landscape.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Medicinal Marijuana Association

FEBRUARY 14, 2024

It’s essential to consult with a veterinarian experienced in cannabis treatment to determine the right product and dosage for your pet. By incorporating cannabis into your pet’s treatment plan under the guidance of a veterinarian, you may notice a significant improvement in their appetite.

Pets 98

Pets Medicine Treatment Conditions 98

Veriheal

JUNE 1, 2023

It had passed through the Senate and the Public Safety and Health committees, but the Assembly Appropriations Committee gutted its main provisions. SB 58, on the other hand, needed to pass through only the Public Safety and Health Committee, hence its accelerated progression to the floor. because there is no public hearing.”

Legalization 91

Legalization Decriminalization Legislation Therapy 91

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

Medicinal Marijuana Association

FEBRUARY 14, 2024

It’s essential to consult with a veterinarian experienced in cannabis treatment to determine the right product and dosage for your pet. By incorporating cannabis into your pet’s treatment plan under the guidance of a veterinarian, you may notice a significant improvement in their appetite.

Pets 95

Pets Medicine Treatment Conditions 95

Cannabis Law Report

JUNE 17, 2021

There are all-natural alternatives like CBD that may offer effective relief for mental health disorders, in addition to prescription medications and therapies. Finding the proper therapy combination might feel like an uphill battle, leaving people unhappy and in no better mental health. The topic of GAD and humans needs more study. .

Oil 104

Oil CBD Therapy Treatment 104

MMJ Recs

JANUARY 24, 2024

Michigan, a state at the forefront of progressive healthcare initiatives, has implemented its own Medical Marijuana Program for years now in order to implement alternative treatments into mainstream medical care. The regulatory framework encompasses licensing, cultivation, and distribution, emphasizing safety and accountability.

Programs 52

Programs Marijuana Access Chronic Pain 52

Cannabis Law Report

JUNE 14, 2022

Those values guide our joint efforts to change perceptions about psychedelic assisted therapies, raise awareness of the scientific advances and, ultimately, bring better health to European citizens. Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD.

Access 52

Access Therapy Clinical Trials Treatment 52

Cannabis Law Report

JUNE 12, 2021

She says the treatment did little but left her feeling numb and unable to heal. “At that time there weren’t any options for this type of treatment in Canada, so we decided together on a clinic in California.” The treatments were carefully dosed and conducted under medical supervision.

Therapy 105

Therapy Treatment Medicine Sleep 105

PrestoDoctor

OCTOBER 11, 2023

In recent years, there has been growing interest in exploring alternative therapies for individuals with ASD. However, as part of a comprehensive treatment plan, CBD may offer a complementary approach to address some of the social symptoms associated with ASD. It is important to approach CBD as part of a comprehensive treatment plan.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Canna Law Blog

DECEMBER 16, 2021

The “purpose or general idea of bill” provides a good summary: this legislation would “create psilocybin service centers to provide innovative treatment options for ailments such as PTSD, depression, alcohol dependency, anxiety, among others.” Rules and Restrictions.

Legislation 96

Legislation Treatment Therapy Conditions 96

Canna Law Blog

FEBRUARY 24, 2020

Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver , and Santa Cruz have decriminalized psilocybin to varying degrees. There is a possibility for local jurisdictions to “opt out.”.

Decriminalization 130

Decriminalization Therapy Research and Development Treatment 130

Cannabis Law Report

OCTOBER 9, 2021

As traditional treatment has proven inadequate at both the individual and public health level, the Commonwealth has a responsibility to research alternative options.

Therapy 52

Therapy Clinical Trials Treatment Legislation 52

Veriheal

AUGUST 24, 2022

Now, a psychedelic-focused bill aimed at reforming laws surrounding psychedelics further in the state has successfully qualified for the November ballot. In May 2022, Connecticut’s governor signed a budget bill that included a provision for the implementation of psychedelic-assisted therapy treatment centers. city to do so.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

FEBRUARY 14, 2020

Consumer products law blog. Class actions against CBD companies proliferate under federal and state law. However, according to the federal Food, Drug & Cosmetic Act and FDA regulations and guidance, CBD products cannot be marketed as food additives, dietary supplements, or for therapeutic uses and treatment of diseases.

State Laws 59

State Laws Law CBD Food 59

Cannabis Law Report

JULY 24, 2021

“The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

JANUARY 20, 2022

Robinson is Founding Partner of Mr. Cannabis Law – a full service law firm focused on the cannabis and psychedelic industries; Co-Founder of Mr. Psychedelic Law – a non-profit focused on psychedelic legal reform; and Managing Principal of Iter Investments – a venture capital firm deploying capital across the psychedelic ecosystem.

Therapy 52

Therapy Research and Development Access Events 52

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer and prostate cancer. Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws.

Data 100

Data Research and Development Clinical Trials Therapy 100